- Udyam number
- UDYAM-MH-20-0041075

About Bda Pharma Private Limited
Data last updated:
Bda Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC180992. Its GSTIN is 27AADCB4215E1Z5 (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Santosh Deshpande (Managing Director) and Shubhankar Santosh Deshpande.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.16 F – 5 6 & 7 First Floor Katol Bypass Tawkkal Lay – Out Ring Road Wadi, Nagpur, Maharashtra, India – 440023.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.34 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹1.58 Cr (net margin 11%) and EBITDA of ₹2.12 Cr (EBITDA margin 14.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over five years.
The company has about 31 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: BDA Pharma. As per MCA filings, the company has open charges of ₹3.9 Cr and satisfied charges of ₹1.99 Cr on record.
Bda Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-20-0041075). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bdapharma.com.
Company details
Recognitions & Rankings of Bda Pharma
Contact details
Bda Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its website is bdapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.16 F – 5 6 & 7 First Floor Katol Bypass Tawkkal Lay – Out Ring Road Wadi, Nagpur, Maharashtra, India – 440023
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bda Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bda Pharma operates one associated brand: BDA Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Marketing of pharmaceutical formulations in India and global markets by a certified company. | bdapharma.com |
Business activity
The main business activity of Bda Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bda Pharma Private Limited, buy the company report.
Financials of Bda Pharma Private Limited
FY 2025 filings availableBda Pharma Private Limited reported revenue of ₹14.34 Cr (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.8% | ||||
| Net Profit Margin | 11% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bda Pharma Private Limited, buy the company report.
Board of directors of Bda Pharma Private Limited
Bda Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubhankar Santosh Deshpande | Director | 07 Aug 2020 | 6 Years 3 Months | Current |
| Santosh Deshpande Also directs: Odypharm India Private Limited, Bda Health Care Private Limited, Bda Laboratories Private Limited and 2 more | Managing Director | 09 Apr 2008 | 18 Years 7 Months | Current |
Peer comparison
Bda Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ryesino Pharmaceuticals Private Limited | ₹14.49 Cr (FY 2024) | 11.0% | Uttar Pradesh, India | |||
| Shree Raghupati Trading Private Limited | ₹14.44 Cr (FY 2024) | 11.0% | Lucknow, Uttar Pradesh, India | |||
| Bda Pharma Private Limitedthis company | ₹14.34 Cr (FY 2025) | ₹1.58 Cr | 11% | -16.0% | 31 | Nagpur, Maharashtra, India |
| Maiden Distributors Limited | ₹14.32 Cr (FY 2025) | -4.0% | New Delhi, Delhi, India | |||
| LG Chem Life Sciences India Private Limited | ₹14.3 Cr (FY 2025) | 298.0% | New Delhi, Delhi, India | |||
| Competent Pharma Private Limited | ₹14.29 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Sixer Trading Private Limited | ₹14.28 Cr (FY 2025) | -10.0% | Thane, Maharashtra, India |
To see the full peer comparison of Bda Pharma Private Limited, buy the company report.
Auditor
Bda Pharma Private Limited is audited by A H S K & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A H S K & Co. | FY 2023 | 113999 |
Shareholding
The shareholding of Bda Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bda Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Feb 2025 | 101056093 | Others | ₹2.3 Cr | Open | |
| 26 Oct 2024 | 101000450 | Others | ₹1.6 Cr | Open | |
| 27 Sep 2018 | 100210657 | Yes Bank Limited | ₹1.99 Cr | Satisfied |
To see the full charge records of Bda Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Bda Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bda Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bda Pharma Private Limited has a workforce of 31 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 31 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Bda Pharma Private Limited, buy the company report.
GST
Bda Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCB4215E1Z5 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bda Pharma Private Limited, buy the company report.
Recent activity
Bda Pharma Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Shubhankar Santosh Deshpande ceased to be Additional Director on 31 Dec 2020.
2 earlier events are in the company report.
Frequently asked questions
Bda Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 April 2008 (18+ years old) and is registered under CIN U24239MH2008PTC180992.
Bda Pharma has 2 current directors:
- Santosh Deshpande - Managing Director
- Shubhankar Santosh Deshpande - Director
The latest financial statements of Bda Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bda Pharma is 27AADCB4215E1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bda Pharma is U24239MH2008PTC180992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bda Pharma was incorporated on 09 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bda Pharma by revenue are Ryesino Pharmaceuticals Private Limited, Shree Raghupati Trading Private Limited, Maiden Distributors Limited, LG Chem Life Sciences India Private Limited, Competent Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Shubhankar Santosh Deshpande ceased to be Additional Director on 31 Dec 2020. Ulhasrao Sitaram Deshpande ceased to be Director on 17 Sep 2020. Shubhankar Santosh Deshpande was appointed as Director on 07 Aug 2020. Bda Pharma has 6 board changes on record in total.
Yes, Bda Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-20-0041075).
Bda Pharma can be reached through the website bdapharma.com. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Bda Pharma is at Plot No.16 F – 5 6 & 7 First Floor Katol Bypass Tawkkal Lay – Out Ring Road Wadi, Nagpur, Maharashtra, India – 440023.

